Release Hydroxychloroquine to American citizens as an OTC (Over-The-Counter) drug for preventing and curing COVID-19
Hydroxychloroquine (HCQ) has been FDA approved for over 65 years and has been used billions of times throughout the entire world without restriction. For many decades it has been given to: pregnant women, breastfeeding women, children, elderly patients, immune compromised patients and healthy persons. In the USA it is used most often in three situations:
systemic lupus erythematosus (SLE),
rheumatoid arthritis (RA),
and as malaria prophylaxis for travelers.
These three situations happen to represent three different types of populations. Patients with SLE are immune compromised. Patients with RA are elderly. Travelers are younger and typically healthy. Although all doctors can and do prescribe HCQ, because it is most commonly used for SLE and RA, rheumatology specialists are the physicians in America who prescribe it the most. It is in the safest category of medication and it is virtually always safely used.
Safety Studies:
It is self-evident that HCQ is safe from the fact that it has been FDA approved for 65 years and has been used many billions of times all over the world and it is over the counter in most of the world, certainly pre-2020. It is the #1 most used medication in India, the second most populous nation on the planet with 1.3 billion people. If an American travels to a location where malaria is endemic, per the CDC, they would start HCQ before they left for their trip. There has never been an allegation that HCQ is not safe until 2020. The only allegations of HCQ not being safe relate to a potential heart problem. The media has stated this so often that many people, including physicians, think there is a potential heart problem. However the evidence is overwhelming that HCQ is very low risk.
Since thousands of board certified physicians across the country have now had great success with its use and effectiveness at curing COVID-19, it should therefore now be fully released to all American citizens desiring to protect the health and lives of themselves and their loved ones. This should be done by permitting over-the-counter (OTC) use of hydroxychloroquine (HCQ) to protect against COVID-19 under an emergency EO.
White Paper on Hydroxychloroquine:
http://americasfrontlinedocs.com/wp-content/uploads/2020/07/White-Paper-on-HCQ-2020.2.pdf
systemic lupus erythematosus (SLE),
rheumatoid arthritis (RA),
and as malaria prophylaxis for travelers.
These three situations happen to represent three different types of populations. Patients with SLE are immune compromised. Patients with RA are elderly. Travelers are younger and typically healthy. Although all doctors can and do prescribe HCQ, because it is most commonly used for SLE and RA, rheumatology specialists are the physicians in America who prescribe it the most. It is in the safest category of medication and it is virtually always safely used.
Safety Studies:
It is self-evident that HCQ is safe from the fact that it has been FDA approved for 65 years and has been used many billions of times all over the world and it is over the counter in most of the world, certainly pre-2020. It is the #1 most used medication in India, the second most populous nation on the planet with 1.3 billion people. If an American travels to a location where malaria is endemic, per the CDC, they would start HCQ before they left for their trip. There has never been an allegation that HCQ is not safe until 2020. The only allegations of HCQ not being safe relate to a potential heart problem. The media has stated this so often that many people, including physicians, think there is a potential heart problem. However the evidence is overwhelming that HCQ is very low risk.
Since thousands of board certified physicians across the country have now had great success with its use and effectiveness at curing COVID-19, it should therefore now be fully released to all American citizens desiring to protect the health and lives of themselves and their loved ones. This should be done by permitting over-the-counter (OTC) use of hydroxychloroquine (HCQ) to protect against COVID-19 under an emergency EO.
White Paper on Hydroxychloroquine:
http://americasfrontlinedocs.com/wp-content/uploads/2020/07/White-Paper-on-HCQ-2020.2.pdf
View Comments